MSI occurs in approximately 15% of sporadic CRCs and is mostly associated with MLH-1 hypermethylation [115,116], but also with phosphatase and tensin homolog (PTEN) hypermethylation in CRC tumors with high MSI (MSI-H) [117,118,119]. This evidence concerns the gene MLH1 and colorectal carcinoma.